Home Markets US FDA approves monthly maintenance dosing for Biogen/Eisai Alzheimer’s drug US FDA approves monthly maintenance dosing for Biogen/Eisai Alzheimer’s drug Andrew M Jan 27, 2025 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/us-fda-approves-monthly-maintenance-dosing-for-biogeneisai-alzheimers-drug-3830993 Biogen Eisai FDA Market Updates